Home
>
National Drug Code (NDC)
>
Erythrocin Lactobionate
Erythrocin Lactobionate - 0409-6482-01 - (ERYTHROMYCIN LACTOBIONATE)
Drug Information of Erythrocin Lactobionate
| Product NDC: | 0409-6482 |
| Proprietary Name: | Erythrocin Lactobionate |
| Non Proprietary Name: | ERYTHROMYCIN LACTOBIONATE |
| Active Ingredient(s): | 500 mg/10mL & nbsp; ERYTHROMYCIN LACTOBIONATE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Erythrocin Lactobionate
| Product NDC: | 0409-6482 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050609 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19860924 |
Package Information of Erythrocin Lactobionate
| Package NDC: | 0409-6482-01 |
| Package Description: | 10 VIAL in 1 TRAY (0409-6482-01) > 10 mL in 1 VIAL |
NDC Information of Erythrocin Lactobionate
| NDC Code | 0409-6482-01 |
| Proprietary Name | Erythrocin Lactobionate |
| Package Description | 10 VIAL in 1 TRAY (0409-6482-01) > 10 mL in 1 VIAL |
| Product NDC | 0409-6482 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ERYTHROMYCIN LACTOBIONATE |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19860924 |
| Marketing Category Name | NDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | ERYTHROMYCIN LACTOBIONATE |
| Strength Number | 500 |
| Strength Unit | mg/10mL |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
